Business Context and Reporting Period
Company: BIO-RAD LABORATORIES, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: February 10, 2022
Reporting Period: Quarter ended December 31, 2021
This filing serves as a notification that the company announced its financial results for the fourth quarter of 2021. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the body of this Form 8-K.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the announcement of results but does not include specific management commentary, guidance, or outlook within the text provided.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt.
Unusual Items: None reported in the text of this filing.
Important Facts for Investors to Verify
- Review Exhibit 99.1 (Press Release) for actual revenue, earnings per share, and cash flow figures for the quarter ended December 31, 2021.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any updated full-year 2022 guidance or forward-looking statements in the press release.
- Confirm the status of the company's Class A (BIO) and Class B (BIOb) common stock trading on the New York Stock Exchange.